U.S. flag

An official website of the United States government

NM_000527.5(LDLR):c.940G>A (p.Gly314Arg) AND Cardiovascular phenotype

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Aug 9, 2024
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002372047.3

Allele description [Variation Report for NM_000527.5(LDLR):c.940G>A (p.Gly314Arg)]

NM_000527.5(LDLR):c.940G>A (p.Gly314Arg)

Gene:
LDLR:low density lipoprotein receptor [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
19p13.2
Genomic location:
Preferred name:
NM_000527.5(LDLR):c.940G>A (p.Gly314Arg)
HGVS:
  • NC_000019.10:g.11107514G>A
  • NG_009060.1:g.23134G>A
  • NM_000527.5:c.940G>AMANE SELECT
  • NM_001195798.2:c.940G>A
  • NM_001195799.2:c.817G>A
  • NM_001195800.2:c.436G>A
  • NM_001195803.2:c.559G>A
  • NP_000518.1:p.Gly314Arg
  • NP_000518.1:p.Gly314Arg
  • NP_001182727.1:p.Gly314Arg
  • NP_001182728.1:p.Gly273Arg
  • NP_001182729.1:p.Gly146Arg
  • NP_001182732.1:p.Gly187Arg
  • LRG_274t1:c.940G>A
  • LRG_274:g.23134G>A
  • LRG_274p1:p.Gly314Arg
  • NC_000019.9:g.11218190G>A
  • NM_000527.4:c.940G>A
  • c.940G>A
Protein change:
G146R
Links:
LDLR-LOVD, British Heart Foundation: LDLR_000695; dbSNP: rs72658858
NCBI 1000 Genomes Browser:
rs72658858
Molecular consequence:
  • NM_000527.5:c.940G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001195798.2:c.940G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001195799.2:c.817G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001195800.2:c.436G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001195803.2:c.559G>A - missense variant - [Sequence Ontology: SO:0001583]
Functional consequence:
no known functional consequence - Comment(s)

Condition(s)

Name:
Cardiovascular phenotype
Identifiers:
MedGen: CN230736

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002685014Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Uncertain significance
(Aug 9, 2024)
germlineclinical testing

PubMed (10)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Diagnosis of families with familial hypercholesterolaemia and/or Apo B-100 defect by means of DNA analysis of LDL-receptor gene mutations.

Widhalm K, Dirisamer A, Lindemayr A, Kostner G.

J Inherit Metab Dis. 2007 Apr;30(2):239-47. Epub 2007 Mar 8.

PubMed [citation]
PMID:
17347910

Low-density lipoprotein receptor gene familial hypercholesterolemia variant database: update and pathological assessment.

Usifo E, Leigh SE, Whittall RA, Lench N, Taylor A, Yeats C, Orengo CA, Martin AC, Celli J, Humphries SE.

Ann Hum Genet. 2012 Sep;76(5):387-401. doi: 10.1111/j.1469-1809.2012.00724.x.

PubMed [citation]
PMID:
22881376
See all PubMed Citations (10)

Details of each submission

From Ambry Genetics, SCV002685014.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (10)

Description

The p.G314R variant (also known as c.940G>A), located in coding exon 6 of the LDLR gene, results from a G to A substitution at nucleotide position 940. The glycine at codon 314 is replaced by arginine, an amino acid with dissimilar properties. However, this change occurs in the last base pair of coding exon 6 and may have some effect on normal mRNA splicing. This variant (also described as legacy p.G293R) has been reported in hypercholesterolemia cohorts; however, clinical details were limited in many cases (Widhalm K et al. J Inherit Metab Dis, 2007 Apr;30:239-47; Durst R et al. Atherosclerosis, 2017 02;257:55-63; Futema M et al. Atherosclerosis, 2017 05;260:47-55; Turkyilmaz A et al. Metab Syndr Relat Disord, 2021 08;19:340-346). Limited functional analyses suggested no significant impact (Thormaehlen AS et al. PLoS Genet, 2015 Feb;11:e1004855). This nucleotide position is not well conserved in available vertebrate species. In silico splice site analysis predicts that this alteration will not have any significant effect on splicing. This amino acid position is not well conserved in available vertebrate species. In addition, as a missense substitution this is predicted to be deleterious by in silico analysis. Based on the available evidence, the clinical significance of this variant remains unclear.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Feb 25, 2025